On-demand webinar offers actionable insights as you develop your protocols.

Many crucial considerations impact a cell and gene therapy developer’s apheresis center selection strategy and ability to efficiently scale processes.

When collection processes or protocols differ from those in place at a center, there are likely implications for training, forms and standard operating procedures. This can potentially delay a first collection.

During the on-demand webinar, our panelists discuss:

  • Common protocol decisions cell and gene therapy developers make along the product collection pathway that can impact ability to scale
  • Specific considerations for collecting starting material for allogeneic cell therapies
  • Factors for post-collection transport and processing to ensure efficient delivery of starting material to the manufacturer


Lacey Anderson
Senior Manager, Collection Network Management
Be The Match BioTherapies®

Sara Butler
Network Liaison, Collection Network Management
Be The Match BioTherapies

Allison Montalvo
Program Manager, Oncology
Janssen (A division of J&J)